Mualliflar

  • Равшанова Н.Б., Шакиров С.А.

##semicolon##

молочная железа, хроническое воспаление, иммуногистохимия, Ki-67, CD45, p53, пролиферация.

##submission.citations##

1. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001. Vol. 357, No. 9255. P. 539-545.

2. Vendramini-Costa D.B., Carvalho J.E. Molecular Link Mechanisms between Inflammation and Cancer. Curr Pharm Des. 2012. Vol. 18, No. 26. P. 3831-3852.

3. Ham M., Moon A. Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharm Res. 2013. Vol. 36, No. 12. P. 1419-1431.

4. Tower H., Ruppert M., Britt K. The Immune Microenvironment of Breast Cancer Progression. Cancers (Basel). 2019. Vol. 11, No. 9. Article 1375.

5. Wynn T.A., Vannella K.M. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016. Vol. 44, No. 3. P. 450-462.

6. D’Alfonso T.M., Ginter P.S., Shin S.J. A Review of Inflammatory Processes of the Breast with a Focus on Diagnosis in Core Biopsy Samples. J Pathol Transl Med. 2015;49(4):279-287. doi:10.4132/jptm. 2015.06.11.

7. Cheng L., Reddy V., Solmos G., Watkins L., Cimbaluk D., Bitterman P., Ghai R., Gattuso P. Mastitis, a Radiographic, Clinical, and Histopathologic Review. Breast J. 2015;21(4):403-409. doi:10.1111/ tbj.12430.

8. Amin A.L., Purdy A.C., Mattingly J.D., Kong A.L., Termuhlen P.M. Benign breast disease. Surg Clin North Am. 2013;93(2):299-308. doi: 10.1016/j.suc. 2013.01.001.

9. Onstad M., Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am. 2013;40(3):459-473. doi: 10.1016/j.ogc.2013.05.004.

10. AbdelHadi M.S.A., Bukhari H.A. Breast infections in non-lactating women. J Family Community Med. 2005;12(3):133-137.